Three cases of extreme elevation of serum alpha fetoprotein (>10,000 ng/mL) with decompensated cirrhosis without demonstrable hepatocellular carcinoma are reported. While 2 patients died of liver failure, 1 survived after liver transplantation. Extreme elevation of alpha fetoprotein not associated with hepatocellular carcinoma in liver cirrhosis heralds an ominous prognosis necessitating urgent liver transplantation.
YaoF.Y.. Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.J Clin Gastroenterol2003; 36: 440–2.
2.
BaeJ.S., ParkS.J., ParkK.B.. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.Korean J Intern Med2005; 20: 80–5.
3.
SteinD.F., MyaingM.. Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis.Dig Dis Sci2002; 47: 2686–90.
4.
CheemaA.W., HirschtrittT., Van ThielD.H.. Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.Hepatogastroenterology2004; 51: 1676–8.
5.
LeeH.S., ChungY.H., KimC.Y.. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.Hepatology1991; 14: 68–72.
6.
SugimotoM., ItsukaichiT., IshiiK.. Marked increase in serum alpha-fetoprotein level in cirrhosis: a case report.Am J Gastroenterol1987; 82: 69–71.
7.
BergmannJ.F., LangF., DechyH., DorraM.. Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.Am J Gastroenterol1985; 80: 810–2.
8.
BourgauxJ.F., PonsodaP., RaffanelC., RibardD., PouderouxP., BalmesJ.L.. Highly elevated alphafetoprotein and hepatic cirrhosis. It is not always hepatocarcinoma.Presse Med2001; 30: 486–7.
9.
MatsushitaK., TanabeG., AikouT.. High serum alpha-fetoprotein concentration associated with pseudoinfarction of a cirrhotic liver: report of a case.Surg Today1996; 26: 818–21.
10.
DiBisceglieA.M., HoofnagleJ.H.. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.Cancer1989; 64: 2117–20.
11.
Di BisceglieA.M., SterlingR.K., ChungR.T.. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.J Hepatol2005; 43: 434–41.
12.
BayatiN., SilvermanA.L., GordonS.C.. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.Am J Gastroenterol1998; 93: 2452–6.
13.
CollazosJ., GenollaJ., RuibalA.. Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation.Int J Biol Markers1992; 7: 97–102.
14.
KhienV.V., MaoH.V., ChinhT.T.. Clinical evaluation of lentil lectin-reactive alpha fetoprotein-L3 in histology-proven hepatocellular carcinoma.Int J Biol Markers2001; 16: 105–11.
15.
AlexandrakisM.G., MoschendraJ., KyriakouD.S., AlexandrakiR., KouromalisE.. Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites.Int J Biol Markers2001; 16: 45–9.
16.
AlpertE., FellerE.R.. Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.Gastroenterology1978; 74: 856–8.
